ZIVO Bioscience, Inc. (NASDAQ:ZIVO – Get Free Report) shares crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $3.61 and traded as high as $5.25. ZIVO Bioscience shares last traded at $5.00, with a volume of 2,015 shares traded.
ZIVO Bioscience Price Performance
The company has a market cap of $20.76 million, a P/E ratio of -1.02 and a beta of 0.10. The stock has a 50-day moving average of $3.69 and a 200 day moving average of $6.52.
About ZIVO Bioscience
ZIVO Bioscience is a clinical-stage biotechnology company focused on developing precision live biotherapeutics to prevent and treat gastrointestinal infections in both animal and human health markets. The company applies synthetic biology, microbiology and fermentation technologies to engineer proprietary bacterial strains that produce targeted lactic acid and antimicrobial compounds. Its pipeline includes ZB-01, an orally administered therapy for recurrent Clostridioides difficile infections in humans, and ZB-02, a feed-additive candidate aimed at reducing Salmonella colonization in poultry.
Founded in 2016 and headquartered in Carlsbad, California, ZIVO Bioscience leverages exclusive licensing agreements with academic institutions to advance its lead programs through preclinical and early clinical development.
Further Reading
- Five stocks we like better than ZIVO Bioscience
- These Stocks Could Win as Wall Street Looks Beyond AI Software
- D.R. Horton Is Defying the Housing Gloom
- Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire
- Broadcom and OpenAI Unveil Jalapeño: An Early Step to Massive AI Growth Potential
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
